Answers are grounded in this paper and cite their sources.
Expert review evaluates MYNX CONTROL outcomes in femoral artery access, highlighting implications for safety and technique accuracy.
INTRODUCTION: Vascular closure devices (VCDs) enable rapid hemostasis after femoral arterial access and support early mobilization and improved patient comfort. MYNX CONTROL is an extravascular polyethylene glycol based closure system designed to seal femoral arteriotomies without leaving permanent intraluminal material. AREAS COVERED: This expert review summarizes the device concept and mechanism of action and critically appraises the available clinical evidence on technical success and access site complications in 5-7 Fr femoral arterial closure. Differences in reported outcomes across published cohorts are examined in the context of patient selection, femoral access characteristics, and procedural technique, with particular attention to factors that increase the risk of maldeployment. EXPERT OPINION: MYNX CONTROL can provide reliable hemostasis with a low incidence of major access site complications when appropriately deployed. As with most devices its performance is strongly dependent in using the appropriate technique. It is widely accepted that reliance on tactile feedback alone is insufficient in challenging anatomy. Adjunctive imaging guidance enhances deployment accuracy and procedural safety.Optimal outcomes require careful access site selection and operator training that includes competence in vascular ultrasound.
No takes yet. Share an insight, caveat, or question.
Goulianou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: